Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)
Membrane transporters have a crucial role in compounds’ brain drug delivery. They allow not only the penetration of a wide variety of different compounds to cross the endothelial cells of the blood–brain barrier (BBB), but also the accumulation of them into the brain parenchymal cells. Solute carrie...
Main Authors: | Johanna Huttunen, Santosh Kumar Adla, Magdalena Markowicz-Piasecka, Kristiina M. Huttunen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/6/1234 |
Similar Items
-
A substrate‐based ontology for human solute carriers
by: Eva Meixner, et al.
Published: (2020-07-01) -
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity
by: Alessandro Lavoro, et al.
Published: (2023-06-01) -
Peptide Shuttles for Blood–Brain Barrier Drug Delivery
by: Macarena Sánchez-Navarro, et al.
Published: (2022-09-01) -
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
by: Magdalena Kurtyka, et al.
Published: (2024-06-01) -
The Role of Transporters in Future Chemotherapy
by: Johanna Huttunen, et al.
Published: (2022-05-01)